Th17 immune response in inflammatory bowel disease: Future roles and opportunities for lactic acid bacteria and bioactive compounds released in fermented milk

Background: Evidence have shown that Th1- and Th17-related cytokines are often elevated in inflammatory bowel diseases (IBD). Hence, targeting Th17 cells or their effector cytokines represents an attractive alternative for treatment IBD. In this context, recent evidence have indicated that ferment...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
מחברים אחרים:	Santiago-Lopez, Lourdes, Abraham, Wall-Medrano, Hernandez-Mendoza, Adrian, Vallejo-Cordoba, Belinda, Gonzalez-Cordova, Aaron Fernando
פורמט:	Artículo
שפה:	en_US
יצא לאור:	2021
נושאים:	citokine TH17 Fermented milk Inflamatory bowel disease IBD info:eu-repo/classification/cti/3
גישה מקוונת:	https://doi.org/10.1016/j.tifs.2021.03.051 https://www.sciencedirect.com/science/article/abs/pii/S0924224421002430
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

היה/י הראשונ/ה לכתוב הערה!

Th17 immune response in inflammatory bowel disease: Future roles and opportunities for lactic acid bacteria and bioactive compounds released in fermented milk

פריטים דומים